HRP950217B1 - Novel erythromycin derivatives, method for preparing the same and use thereof as drugs - Google Patents

Novel erythromycin derivatives, method for preparing the same and use thereof as drugs

Info

Publication number
HRP950217B1
HRP950217B1 HR950217A HRP950217A HRP950217B1 HR P950217 B1 HRP950217 B1 HR P950217B1 HR 950217 A HR950217 A HR 950217A HR P950217 A HRP950217 A HR P950217A HR P950217 B1 HRP950217 B1 HR P950217B1
Authority
HR
Croatia
Prior art keywords
drugs
preparing
same
erythromycin derivatives
novel erythromycin
Prior art date
Application number
HR950217A
Other languages
English (en)
Inventor
Constantin Agouridas
Yannick Benedetti
Jean-Francois Chantot
Alexis Denis
Odile Le Martret
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of HRP950217A2 publication Critical patent/HRP950217A2/hr
Publication of HRP950217B1 publication Critical patent/HRP950217B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HR950217A 1994-04-08 1995-04-07 Novel erythromycin derivatives, method for preparing the same and use thereof as drugs HRP950217B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9404154A FR2718450B1 (fr) 1994-04-08 1994-04-08 Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Publications (2)

Publication Number Publication Date
HRP950217A2 HRP950217A2 (en) 1997-08-31
HRP950217B1 true HRP950217B1 (en) 2004-06-30

Family

ID=9461886

Family Applications (1)

Application Number Title Priority Date Filing Date
HR950217A HRP950217B1 (en) 1994-04-08 1995-04-07 Novel erythromycin derivatives, method for preparing the same and use thereof as drugs

Country Status (49)

Country Link
US (2) US5656607A (cs)
EP (1) EP0676409B1 (cs)
JP (1) JP3000023B2 (cs)
KR (1) KR100317148B1 (cs)
CN (1) CN1059445C (cs)
AP (1) AP587A (cs)
AT (1) ATE234853T1 (cs)
AU (1) AU684939B2 (cs)
BG (1) BG61916B1 (cs)
BR (1) BR9506147A (cs)
CA (1) CA2164638C (cs)
CO (1) CO4370097A1 (cs)
CZ (1) CZ296005B6 (cs)
DE (1) DE69529934T2 (cs)
DK (1) DK0676409T3 (cs)
DZ (1) DZ1869A1 (cs)
EE (1) EE04498B1 (cs)
ES (1) ES2189820T3 (cs)
FI (1) FI111264B (cs)
FR (1) FR2718450B1 (cs)
GB (1) GB2288174A (cs)
GE (1) GEP19991836B (cs)
HR (1) HRP950217B1 (cs)
HU (1) HU215396B (cs)
IL (1) IL112954A (cs)
IS (1) IS1865B (cs)
JO (1) JO1850B1 (cs)
LV (1) LV11182B (cs)
MA (1) MA23501A1 (cs)
MD (1) MD663G2 (cs)
MY (1) MY114672A (cs)
NO (1) NO308361B1 (cs)
NZ (1) NZ284498A (cs)
OA (1) OA10200A (cs)
PE (1) PE2896A1 (cs)
PL (1) PL180837B1 (cs)
PT (1) PT676409E (cs)
RO (1) RO115634B1 (cs)
RU (1) RU2141965C1 (cs)
SA (1) SA97170757A (cs)
SI (1) SI0676409T1 (cs)
SK (1) SK284079B6 (cs)
SV (1) SV1995000018A (cs)
TN (1) TNSN95026A1 (cs)
TW (1) TW316908B (cs)
UA (1) UA44705C2 (cs)
WO (1) WO1995027720A1 (cs)
YU (1) YU49221B (cs)
ZA (1) ZA952059B (cs)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745289B1 (fr) * 1996-02-28 1998-05-29 Roussel Uclaf Nouveaux derives de l'acide 1(2h) quinoleine carboxylique, leur procede de preparation et leur application a la synthese de produits doues de proprietes antibiotiques
KR20000011071A (ko) * 1996-05-07 2000-02-25 스티븐 에프. 웨인스톡 3-데스클라디노스-2,3-안하이드로에리트로마이신 유도체
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
FR2748746B1 (fr) * 1996-05-14 1998-08-14 Hoechst Marion Roussel Inc Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine
FR2751656B1 (fr) * 1996-07-24 1998-10-16 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
RO121473B1 (ro) * 1996-09-04 2007-06-29 Abbott Laboratories Cetolide 6-o substituite, cu activitate antibacteriană
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
AU4472897A (en) * 1997-03-10 1998-09-29 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
AU6421398A (en) * 1997-03-24 1998-10-20 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
WO1998051696A1 (en) * 1997-05-09 1998-11-19 Pfizer Products Inc. Erythromycin derivatives
US5922683A (en) * 1997-05-29 1999-07-13 Abbott Laboratories Multicyclic erythromycin derivatives
JP2000513026A (ja) * 1997-06-11 2000-10-03 ファイザー・プロダクツ・インク ９−オキシム エリスロマイシン誘導体
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
DE69926005T2 (de) * 1998-09-22 2006-05-18 Pfizer Products Inc., Groton Carbamat- und carbazatketolidantibiotika
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
AU6484199A (en) 1998-12-10 2000-06-26 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
EP1749832A3 (en) * 1998-12-10 2008-03-26 Pfizer Products Incorporated Carbamate and carbazate ketolide antibiotics
FR2789392B1 (fr) * 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
US6458771B1 (en) 1999-04-16 2002-10-01 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
NZ515027A (en) * 1999-04-16 2004-01-30 Kosan Biosciences Inc Erythromycin derivatives as antibiotics
OA11945A (en) * 1999-05-24 2006-04-13 Pfizer Prod Inc 13-Methyl erythromycin derivatives.
US6756359B2 (en) 2001-07-03 2004-06-29 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
CA2488853C (en) 2002-07-01 2016-06-28 Arkion Life Sciences Llc D/B/A/ Bio-Technical Resources Division Process and materials for production of glucosamine and n-acetylglucosamine
CA2529817C (en) * 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
EP1618120A2 (en) * 2003-04-25 2006-01-25 Chiron Corporation Novel ketolide derivatives
JP2006524702A (ja) * 2003-04-25 2006-11-02 カイロン コーポレイション ピリジル置換ケトライド抗体
WO2009055557A1 (en) * 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
WO2010048600A1 (en) * 2008-10-24 2010-04-29 Cempra Pharmaceuticals, Inc. Methods for treating resistant diseases using triazole containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
CN108310000A (zh) 2009-09-10 2018-07-24 森普拉制药公司 治疗疟疾、结核病和mac疾病的方法
CA2793884C (en) 2010-03-22 2019-09-10 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
US9051346B2 (en) 2010-05-20 2015-06-09 Cempra Pharmaceuticals, Inc. Process for preparing triazole-containing ketolide antibiotics
EP2613630A4 (en) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES
IN2014DN08939A (cs) 2012-03-27 2015-05-22 Cempra Pharmaceuticals Inc
RU2015138796A (ru) 2013-03-14 2017-04-19 Семпра Фармасьютикалс, Инк. Способы и составы для лечения респираторных заболеваний
WO2014145210A1 (en) 2013-03-15 2014-09-18 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
CA2908575C (en) 2013-04-04 2021-11-16 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
HK1242920A1 (zh) 2014-10-08 2018-07-06 哈佛大学的校长及成员们 14-元酮内酯及其制备和使用方法
JP2018509452A (ja) 2015-03-25 2018-04-05 プレジデント アンド フェローズ オブ ハーバード カレッジ 修飾デソサミン糖をもつマクロライドおよびその使用
MD1222Z (ro) * 2017-05-31 2018-08-31 ИНСТИТУТ ЭЛЕКТРОННОЙ ИНЖЕНЕРИИ И НАНОТЕХНОЛОГИЙ "D. Ghitu" АНМ Procedeu de tratare a materialului săditor al florilor înainte de plantare
JP7199722B2 (ja) 2019-12-25 2023-01-06 旭精工株式会社 硬貨搬送振分機構及びそれを備えた硬貨識別搬送装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868414A (en) * 1973-01-22 1975-02-25 Merck & Co Inc Tetrahydrofluorene carboxylic acids and related compounds
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
DE2842759A1 (de) * 1978-09-30 1980-04-10 Merck Patent Gmbh Basische aether, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
FR2692579B1 (fr) * 1992-06-19 1995-06-02 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
AU684939B2 (en) 1998-01-08
US5656607A (en) 1997-08-12
ZA952059B (en) 1996-03-13
YU49221B (sh) 2004-11-25
IL112954A0 (en) 1995-06-29
EP0676409A1 (fr) 1995-10-11
CZ296005B6 (cs) 2005-12-14
BG61916B1 (bg) 1998-09-30
NO954942D0 (no) 1995-12-06
WO1995027720A1 (fr) 1995-10-19
FI955913A7 (fi) 1995-12-08
LV11182B (en) 1997-04-20
NO954942L (no) 1996-02-07
IL112954A (en) 2000-07-16
CA2164638A1 (fr) 1995-10-19
NO308361B1 (no) 2000-09-04
HRP950217A2 (en) 1997-08-31
SK284079B6 (sk) 2004-09-08
CO4370097A1 (es) 1996-10-07
FR2718450A1 (fr) 1995-10-13
TNSN95026A1 (fr) 1996-02-06
GEP19991836B (en) 1999-11-05
CA2164638C (fr) 2003-12-30
YU21695A (sh) 1997-12-05
FI955913A0 (fi) 1995-12-08
IS1865B (is) 2003-05-02
TW316908B (cs) 1997-10-01
IS4309A (is) 1995-11-17
JO1850B1 (en) 1995-12-27
RU2141965C1 (ru) 1999-11-27
PT676409E (pt) 2003-08-29
MY114672A (en) 2002-12-31
EP0676409B1 (fr) 2003-03-19
SK154695A3 (en) 1996-10-02
RO115634B1 (ro) 2000-04-28
FR2718450B1 (fr) 1997-01-10
SA97170757A (ar) 2005-12-03
PL311871A1 (en) 1996-03-18
CN1059445C (zh) 2000-12-13
JP3000023B2 (ja) 2000-01-17
UA44705C2 (uk) 2002-03-15
PE2896A1 (es) 1996-02-12
MD663G2 (ro) 1997-07-31
MD663F1 (ro) 1997-01-31
BR9506147A (pt) 1996-04-16
MA23501A1 (fr) 1995-12-31
ATE234853T1 (de) 2003-04-15
HUT73772A (en) 1996-09-30
JPH07278177A (ja) 1995-10-24
AP9500743A0 (en) 1995-07-31
PL180837B1 (pl) 2001-04-30
DZ1869A1 (fr) 2002-02-17
EE04498B1 (et) 2005-06-15
DK0676409T3 (da) 2003-06-23
HU9503505D0 (en) 1996-02-28
HU215396B (hu) 1998-12-28
GB2288174A (en) 1995-10-11
LV11182A (lv) 1996-04-20
GB9506856D0 (en) 1995-05-24
CN1126997A (zh) 1996-07-17
NZ284498A (en) 1997-07-27
AU2310795A (en) 1995-10-30
AP587A (en) 1997-04-29
OA10200A (fr) 1996-12-18
BG100150A (bg) 1996-06-28
EE9500080A (et) 1996-12-16
ES2189820T3 (es) 2003-07-16
SV1995000018A (es) 1997-10-24
FI111264B (fi) 2003-06-30
DE69529934T2 (de) 2003-09-04
DE69529934D1 (de) 2003-04-24
US5760233A (en) 1998-06-02
KR100317148B1 (ko) 2002-06-22
CZ322395A3 (en) 1996-08-14
SI0676409T1 (en) 2003-06-30

Similar Documents

Publication Publication Date Title
HRP950217B1 (en) Novel erythromycin derivatives, method for preparing the same and use thereof as drugs
HU9603038D0 (en) Novel erythromycin derivatives, method for their preparation and their use as drugs
HUP9902576A3 (en) Novel erythromycin derivatives, method for preparing them, and use thereof as drugs
HUP0001115A3 (en) Heterocyclylmethyl-substituted pyrazol derivatives, process for their preparation and pharmaceuticals containing the same
HUP0000658A3 (en) Sulphonamide derivatives, process for their preparation, and their use as medicaments
HUP9900974A3 (en) Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
HUP0104035A3 (en) Novel erythromycin derivatives, preparation method and use as medicines
HUP9800555A3 (en) 3,3-diphenylallylamine derivatives and process for their preparation
EP0599159A3 (de) a-L-Rhamnosidase zur Gewinnung von Rhamnose, ein Verfahren zur Herstellung und ihre Verwendung.
EP0693474A4 (en) NEW BENZYLAMINOETHOXYBENZENE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
HUP9600665A2 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
GB9310075D0 (en) New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
HUP9903424A3 (en) Novel erythromycin derivatives,method for preparing same and use thereof as drugs
HRP931016A2 (en) Thienothiazin derivatives, process for the preparation and application thereof
IL130420A (en) Erythromycin derivatives, method for preparing them and their use as medicine
SI0863139T1 (en) Benzoxazindione derivatives, process for their preparation and their use
HRP930131A2 (en) Amino-ascorbic acid derivatives, process for the preparation and use thereof
ZA9810403B (en) New epothilon derivatives, process for their preparation and their pharmaceutical use.
AU3218195A (en) Alpha-d-pentofuranoside derivatives, process for preparing the same and their use
HU9501546D0 (en) Sulphamide-derivatives, process for their preparation and their use as insecticides
HUP0103997A3 (en) Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines
ZA9610708B (en) Oxaindene derivatives and process for the preparation thereof.
HU9701216D0 (en) New nitropyrazolester derivatives, process for their preparation and their use
SI0794184T1 (en) 6-methoxy-1h-benzotriazole-5-carboxamide derivatives, process for producing the same, and medicinal composition containing the same
SI1165596T1 (en) 14,15-alpha-methylene equilenine derivatives, methods for producing the same and medicaments containing them

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: ROUSSEL UCLAF, FR

Owner name: HOECHST MARION ROUSSEL, FR

Owner name: AVENTIS PHARMA S.A., FR

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20140311

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20150407